Tyra Biosciences, Inc. (TYRA): Price and Financial Metrics
TYRA Price/Volume Stats
Current price | $17.12 | 52-week high | $29.60 |
Prev. close | $16.76 | 52-week low | $10.60 |
Day low | $16.25 | Volume | 604,100 |
Day high | $17.78 | Avg. volume | 189,731 |
50-day MA | $22.07 | Dividend yield | N/A |
200-day MA | $19.15 | Market Cap | 904.04M |
TYRA Stock Price Chart Interactive Chart >
Tyra Biosciences, Inc. (TYRA) Company Bio
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
TYRA Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...